Testing guide
Which test is used—and when?
Tick-borne testing is confusing because the best test can change with the organism, the stage of illness and whether treatment has already started. The table below summarizes which methods are commonly used and the main timing limitations.
| Condition | Common testing approach | Timing problem to know |
|---|---|---|
| Babesiosis | Peripheral blood smear and/or PCR are used to confirm acute infection; serology can provide supportive evidence in appropriate contexts. | Parasitemia can be low or fluctuate; antibody positivity does not by itself prove active symptomatic infection. |
| Lyme disease | CDC recommends FDA-cleared two-step antibody testing when laboratory testing is indicated. | Antibody tests can be falsely negative in the first few weeks before a detectable immune response develops. A typical erythema migrans rash in the right clinical setting is a clinical diagnosis. |
| Anaplasmosis / Ehrlichiosis | PCR on whole blood is most useful early; paired IgG serology can support diagnosis retrospectively. | PCR sensitivity can fall after appropriate antibiotics begin, and acute antibody tests may initially be negative. Treatment should not be delayed for results when clinical suspicion is high. |
| RMSF | Paired serology is often used; PCR may be useful in selected specimens but a negative early test does not exclude disease. | Early serology is often negative. Delaying doxycycline while waiting for confirmation can be dangerous. |
| B. miyamotoi | PCR can be useful during spirochetemia; serology may include GlpQ or other relapsing-fever targets depending on the laboratory. | Standard Lyme serology is not designed to diagnose relapsing-fever Borrelia miyamotoi. |
Tick testing
Testing the tick is different from testing you.
A tick PCR can identify pathogen material in the submitted tick. It cannot establish that transmission occurred. CDC generally advises against using tick-testing results to make treatment decisions.
Understand tick testingHuman testing
Context changes interpretation.
Symptoms, exposure geography, timing, medications and test method all affect what a result means. A “negative” test very early in illness can mean something very different from a negative test later.
Babesia testing deep divePrimary guidance
CDC — Lyme testing and diagnosis
Two-step serology, early window period and interpretation.
Open CDC guidance ↗IDSA — Lyme prevention, diagnosis and treatment
Clinical diagnosis of erythema migrans, high-risk bite prophylaxis and testing recommendations.
Open guideline ↗CDC — Tick-borne rickettsial disease guidance
Why early testing can be negative and why treatment should not wait in suspected RMSF/ehrlichiosis/anaplasmosis.
Open CDC guidance ↗
Products I used + practical support
Products worth knowing about
Cryptolepis and artemisinin are the two products I personally used during my Babesia experience. I am sharing what I used, not prescribing a treatment. The other items are practical support products people may find useful while keeping track of medications, supplements, and hydration.
What I personally used
Cryptolepis sanguinolenta
The Cryptolepis product I personally used. See the Cryptolepis page for the research, limitations, and my experience.
View Cryptolepis on AmazonAmazon affiliate link
What I personally used
Artemisinin
The artemisinin product I personally used. See the Artemisinin page for the research, limitations, and my experience.
View Artemisinin on AmazonAmazon affiliate link
Practical support
Large weekly pill organizer
A simple way to keep prescriptions and supplements organized when a routine gets complicated.
View pill organizer on AmazonAmazon affiliate link
Practical support
Hydration / electrolyte packets
Convenient hydration support for people who want an easy electrolyte option. This is not a Babesia treatment.
View hydration packets on AmazonAmazon affiliate link
Amazon disclosure: As an Amazon Associate I earn from qualifying purchases. Buying through an affiliate link may earn Beat Babesia a commission at no additional cost to you.